Search database
LIST OPTIONS
Filter
8
Filtered Results: 8
Text search: H. Sloot
Featured
Language
Document type
Guidelines
4
No document type
4
Countries / Regions
Guinea-Bissau
1
Germany
1
Kenya
1
Mozambique
1
Brazil
1
Angola
1
Latin America and the Carribbean
1
Western and Central Europe
1
Russia
1
Authors & Publishers
World Health Organization WHO
2
H. Sloot
1
icco (Partner to enterprising people)
1
M. Gaanderse
1
Ministry of Health, Kenya
1
OPS
1
Organización Mundial de la Salud OMS
1
Pan American Health Organization (PAHO), OPS
1
R. Diel, A. Nienhaus
1
R. Knottneruset al.
1
United Nations Office on Drugs and Crime
1
WHO
1
World Drug Report 2017
1
Publication Years
Category
Countries
4
Toolboxes
COVID-19
4
Pharmacy
2
HIV
1
Mental Health
1
TB
1

Guidelines on lobby and advocacy

H. Sloot; M. Gaanderse; R. Knottneruset al. icco (Partner to enterprising people) (2010) C2
Current Issüs Arising from Tuberculosis Screening with Interferon-Gamma- Release Assays (IGRAs) Pneumologie 2015; 69: 271–275
Tercera versión, 1 de febrero del 2022. Estas orientaciones tienen por objetivo contribuir a que los sistemas de salud prioricen los medicamentos esenciales que deben estar disponibles y ser asequibles para manejar los pacientes en las unidades de cuidado intensivos durante las emergencias de salud... more
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022

The drug problem and organized crime, illicit financial flows, corruption and terrorism

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
World Drug Report 2017 -5- Accessed: 14.03.2019
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в оказа... more
Update, 23 de junio de 2022